TickerKhojComparison · NSE · data 2026-11-02
Gujarat Themis Biosyn Ltd vs Senores Pharmaceuticals Ltd.
In plain words
Size: Senores Pharmaceuticals Ltd. is about 1.1 times the market value of Gujarat Themis Biosyn Ltd.
Valuation (P/E): Gujarat Themis Biosyn Ltd 83.8 vs Senores Pharmaceuticals Ltd. 38.9.
Return on equity: Gujarat Themis Biosyn Ltd 17.4% vs Senores Pharmaceuticals Ltd. 13.4%.
Profit growth over 3 years: Senores Pharmaceuticals Ltd. 139.2% a year vs Gujarat Themis Biosyn Ltd -7% a year.
Debt to equity: Gujarat Themis Biosyn Ltd 0.56 vs Senores Pharmaceuticals Ltd. 0.37.
Differences in the numbers, not a recommendation of either stock.
Side by side
| GUJTHEM | SENORES | |
|---|---|---|
| Price | ₹374.3 | ₹1,124.1 |
| Market cap | ₹4,718 cr | ₹5,221 cr |
| P/E | 83.8 | 38.9 |
| P/B | — | 5.2 |
| ROE | 17.4% | 13.4% |
| ROCE | 18.2% | 12.6% |
| Debt / equity | 0.56 | 0.37 |
| Operating margin | 38.9% | 24.3% |
| Dividend yield | 0.18% | 0.00% |
| Sales growth, 3 years (yearly) | 3.8% | 161.6% |
| Profit growth, 3 years (yearly) | -7.0% | 139.2% |
| 1-year return | -19.9% | 45.0% |
| Revenue, last 12 months | ₹174 cr | ₹722 cr |
| Net profit, last 12 months | ₹49 cr | ₹133 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹11 cr | ₹39 cr |
| Quarter profit vs a year earlier | +22.2% | +22.0% |
| Promoter holding | 59.33% | 45.82% |
| Health check | Weak (3.8/10) | Strong (7.3/10) |
Common questions
Which has a higher P/E, Gujarat Themis Biosyn Ltd or Senores Pharmaceuticals Ltd.?
Gujarat Themis Biosyn Ltd trades at the higher P/E (83.8 against 38.9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Gujarat Themis Biosyn Ltd (17.4% against 13.4%).
Which carries more debt?
Gujarat Themis Biosyn Ltd has the higher debt-to-equity ratio (0.56 against 0.37).